Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Operations

v2.4.0.6
Consolidated Statements Of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2010
Consolidated Statements Of Operations [Abstract]      
Revenue $ 69,655 $ 147,849 $ 139,764
Cost of goods sold 46,398 106,297 102,374
Gross profit 23,257 41,552 37,390
Operating expenses:      
Sales and marketing 6,496 10,813 10,770
Research and development 7,727 11,774 11,363
General and administrative 7,615 8,623 9,020
Intangible amortization 548 545 529
Restructuring 550   460
Total operating expenses 22,936 31,755 32,142
Operating income 321 9,797 5,248
Gain on CNS asset sale 31,654    
Other income (expense), net 331 29 17
Interest (expense)   (9) (4)
Income before income taxes and discontinued operations 32,306 9,817 5,261
Income taxes (12,875) 53,304 814
Net income from continuing operations 19,431 63,121 6,075
Discontinued Operations (Note 1):      
Gain on sale of discontinued operations, net of tax expense of $12,359 20,489    
Income from discontinued operations, net of tax expense of $1,447, $53 and $256 for fiscal years 2012, 2011 and 2010, respectively 2,062 4,815 4,252
Net income $ 41,982 $ 67,936 $ 10,327
Basic net income per share:      
Basic net income from continuing operations $ 0.29 $ 0.93 $ 0.09
Basic net income from discontinued operations $ 0.34 $ 0.07 $ 0.06
Basic net income per share $ 0.63 $ 1.00 $ 0.15
Diluted net income per share:      
Diluted net income from continuing operations $ 0.29 $ 0.91 $ 0.09
Diluted net income from discontinued operations $ 0.33 $ 0.07 $ 0.06
Diluted net income per share $ 0.62 $ 0.98 $ 0.15
Weighted-average number of shares outstanding:      
Basic 66,657 67,848 67,987
Effect of dilutive securities: restricted stock, restricted stock units, performance stock units and stock options 1,322 [1] 1,629 [1] 586 [1]
Diluted 67,979 69,477 68,573
[1] The Company had 1.2 million, 2.4 million and 6.1 million options outstanding as of March 31, 2012, 2011 and 2010, respectively, which were not included in the computation of average diluted shares outstanding because they were anti-dilutive.